You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
3 April 2017
Sucampo Acquires Vtesse Inc.
13 March 2014
Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.
10 February 2014
Sucampo Names Peter Greenleaf Chief Executive Officer
22 October 2013
Sucampo Announces Completion of Patient Enrollment in a Phase 3 Clinical Study of Unoprostone Isopropyl for Retinitis Pigmentosa
13 September 2013
Sucampo to Present Data on AMITIZA(R) (lubiprostone) in Chronic Idiopathic Constipation at Annual Meeting of the Swiss Society of Gastroenterology
